Investing Ideas
/
U.K. Pharmaceuticals & Biotech High Growth Potential Companies

U.K. Pharmaceuticals & Biotech High Growth Potential Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Future performance score of at least 3, ordered by Future performance score.

14 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
GSK GSK	UK£13.34	0%	-8.0%	UK£54.4b	UK£18.17	PE21.7x	E23.2%	4.3%
OXB Oxford Biomedica	UK£4.19	-1.4%	90.5%	UK£443.9m	UK£5.33	PS4.6x	E92.5%	n/a
INDV Indivior	UK£9.69	2.3%	-18.3%	UK£1.2b	UK£14.04	PS1.3x	E49.4%	0%
FUM Futura Medical	UK£0.32	-1.2%	24.0%	UK£96.0m	UK£1.34	PS11.4x	E188.3%	n/a
LLAI LungLife AI	UK£0.085	-5.6%	-81.5%	UK£2.7m	UK£1.71	PS112.5x	E101.0%	n/a
GNS Genus	UK£15.32	0.8%	-29.4%	UK£1.0b	UK£24.23	PE127.4x	E31.5%	2.1%
AZN AstraZeneca	UK£104.08	-0.1%	-1.8%	UK£161.4b	UK£139.39	PE31.1x	E18.2%	2.2%
APH Alliance Pharma	UK£0.45	-1.6%	11.0%	UK£243.0m	UK£0.66	PS1.3x	E69.7%	0%
HCM HUTCHMED (China)	UK£2.32	1.3%	-18.0%	UK£2.0b	UK£4.68	PS4.1x	E47.4%	n/a
EAH ECO Animal Health Group	UK£0.71	0%	-34.6%	UK£48.1m	UK£1.60	PE73.1x	E39.2%	0%
DPH Dechra Pharmaceuticals	UK£38.66	0.2%	32.4%	UK£4.4b	UK£37.59	PS5.8x	E62.5%	0%
TRX Tissue Regenix Group	UK£0.58	1.8%	11.5%	UK£41.3m	UK£1.20	PS1.6x	E170.8%	n/a
ERGO Ergomed	UK£13.46	0.1%	3.5%	UK£701.1m	UK£14.34	PE46.7x	E14.2%	n/a
DXRX Diaceutics	UK£1.26	0%	44.3%	UK£106.0m	UK£1.75	PS4.1x	E83.5%	n/a

Page 1 of 1